3 × HEMB (IX) |
X |
Ya5, Ya5, Yb8 |
Hemophilia B |
[23,56] |
2 × HEMA (VIII) |
X |
Yb8, Yb9 |
Hemophilia A |
[23,56] |
2 × CLCN5
|
X |
Ya6, Ya5 |
Dent's disease |
[23,56] |
2 × BTK
|
X |
Y, Y |
X-linked agammaglobulinemia |
[23,56] |
IL2RG |
X |
Ya5 |
X-linked severe combined immunodeficiency disease |
[23,56] |
GK |
X |
Yc1 |
Glycerol kinase deficiency |
[23,56] |
CD40LG |
X |
Yb8 |
Hyper IgM syndrome |
[23,56] |
ATP7A |
X |
Ya5a2 |
Menkes disease |
[23,56] |
CRB1 |
1 |
Y |
Retinitis pigmentosa |
[23,56] |
ZFHX1B |
2 |
Ya5 |
Mowat-Wilson syndrome |
[23,56] |
BCHE |
3 |
Yb8 |
Cholinesterase deficiency |
[23,56] |
OPA1 |
3 |
Yb8 |
Autosomal dominant optic atrophy |
[89] |
CASR |
3 |
Ya4 |
Hypocalciuric hypercalcemia and hyperparathyroidism |
[23,56] |
MLVI2 |
5 |
Ya5 |
Associated with leukemia |
[23,56] |
APC |
5 |
Yb8 |
Hereditary desmoid disease |
[23,56] |
P5N1 |
7 |
Ya5 |
Chronic hemolytic anemia |
[23,56] |
EYA1 |
8 |
Y |
Branchio-oto-renal syndrome |
[23,56] |
LPL |
8 |
Yb9 |
Lipoprotein lipase deficiency |
[23,56] |
POMT1 |
9 |
Ya5 |
Walker Warburg syndrome |
[23,56] |
3 × FGFR2
|
10 |
Ya5, Yb8, Yc1 |
Apert's syndrome |
[23,56] |
TNFRSF6 |
10 |
Yb8 |
Autoimmune lymphoproliferative syndrome |
[23,56] |
C1NH |
11 |
Yc1 |
Complement deficiency |
[23,56] |
AIP |
11 |
Ya5 |
Acute intermittent porphyria |
[23,56] |
GNPTAB |
12 |
Y |
Mucolipidosis |
[90] |
|
|
|
|
|
3 × BRCA2
|
13 |
Ya5, Yc1, Y |
Breast cancer |
[91] |
PMM2 |
16 |
Yb8 |
Congenital disorder of glycosylation type I |
[92] |
BRCA1 |
17 |
Ya5 |
Breast cancer |
[23,56] |
15 × NF1
|
17 |
Y subfamilies |
Neurofibromatosis |
[23,56,57] |